Read + Share
Guo H, Zhang X, Xie S, Chen T, et al. Gefitinib enhances the antitumor immune response against EGFRmutated NSCLC by
upregulating B7H5 expression and activating T cells via CD28H. Int J Oncol 2022;61.
PMID: 36205136
|
 |
|
Guo H, Zhang X, Xie S, Chen T, et al. Gefitinib enhances the antitumor immune response against EGFRmutated NSCLC by
upregulating B7H5 expression and activating T cells via CD28H. Int J Oncol 2022;61.
PMID: 36205136
|
|
|
|